HLA Allele Nomenclature Explained: How to Read HLA-B*15:02 and Typing Resolution

HLA typing results often appear as combinations of letters, numbers, colons, and suffixes. For laboratories developing or evaluating HLA assays, understanding this format is essential. A result such as HLA-B*15:02 is not an arbitrary code. Each part of the designation communicates information about the HLA locus, allele family, and sequence-level differences.

The same allele may also appear in older formats, such as HLA-B*1502, or in a more detailed format, such as HLA-B*15:02:01:01. These names refer to different levels of sequence detail within the HLA nomenclature system.

This guide explains how to read HLA allele names, what each field means, how HLA-B*15:02 should be interpreted, and how typing resolution affects assay design, result reporting, and reference standard selection. The official HLA Nomenclature naming guide and the IPD-IMGT/HLA Database should be consulted when confirming current allele designations.

This article explains HLA nomenclature for laboratory, research, assay development, and quality-control purposes. It is not a substitute for clinical pharmacogenomic or transplant-related guidance.

Key Takeaways

• HLA-B*15:02 identifies an allele at the HLA-B locus.

• HLA-B is the gene or locus, while 15:02 is the allele designation.

• The first two fields generally identify differences that change the encoded protein sequence.

• Third- and fourth-field information provides additional coding or non-coding sequence detail.

• HLA-B*15:02 and HLA-B*1502 are modern and legacy formats for the same two-field designation.

• Typing resolution describes how much allele-level information an assay can distinguish and report.

• A higher-resolution result is not automatically better; it should match the intended use of the assay.

• Reference standards should be characterized at a resolution that supports the laboratory’s reporting requirements.

What Is HLA Allele Nomenclature?

HLA allele nomenclature is the standardized system used to name sequence-defined variants of HLA genes. The HLA system contains highly polymorphic genes, including class I loci such as HLA-A, HLA-B, and HLA-C, as well as class II loci such as HLA-DRB1, HLA-DQB1, and HLA-DPB1.

Because many HLA alleles can differ by only one or a few nucleotides, a short and consistent naming system is necessary. The nomenclature allows laboratories, researchers, registries, manufacturers, and reference material providers to describe the same allele in a standardized way.

The official IPD-IMGT/HLA Database maintains sequences and allele names recognized through the HLA nomenclature system. When a laboratory receives a typing result, the allele name should therefore be interpreted as a sequence-based designation rather than as a simple disease marker or serological label.

How to Read HLA-B*15:02

The designation HLA-B*15:02 can be divided into several parts:

HLA-B

HLA-B identifies the gene locus being tested. HLA-B is a class I HLA gene involved in presenting intracellular peptide fragments to immune cells.

The letter is important because the same numerical allele code can occur at different loci. For example, HLA-A*15:02 and HLA-B*15:02 would not refer to the same gene. The locus must always be included when interpreting or reporting an HLA allele.

The Asterisk

The asterisk separates the gene name from the allele designation:

• HLA-B*15:02

• HLA-A*02:01

• HLA-C*07:02

It indicates that the following numbers describe an allele rather than a serological antigen or a general gene family.

The First Field: 15

The first field identifies the allele family. In many cases, this field has a relationship to a historically defined serological antigen, but the two concepts should not be treated as identical.

For example, HLA-B*15 identifies an allele group within the HLA-B locus. It does not provide enough information to identify one specific sequence-defined allele.

Different alleles within the same first-field group may have different nucleotide and protein sequences. Therefore, a report that only states HLA-B*15 contains less information than one that states HLA-B*15:02.

The Second Field: 02

The second field identifies a specific subtype within the allele family. Differences between the first and second fields generally correspond to one or more nucleotide substitutions that change the amino acid sequence of the encoded protein.

Therefore, HLA-B*15:02 provides more sequence-level information than HLA-B*15. It identifies a particular two-field allele designation rather than only an allele group.

The second field is especially important when a laboratory must distinguish alleles with different protein sequences for transplantation, pharmacogenomic testing, research, or assay validation.

What Do the Additional Fields Mean?

Some HLA alleles contain three or four fields:

• HLA-B*15:02:01

• HLA-B*15:02:01:01

The additional fields provide sequence information that does not necessarily change the encoded protein.

Two-Field Designation

A two-field designation contains the allele family and protein-level subtype:

HLA-B*15:02

This level is commonly used when the laboratory needs to distinguish alleles that encode different protein sequences but does not need to report synonymous or non-coding differences.

Third Field

The third field distinguishes alleles that encode the same protein but differ by synonymous nucleotide substitutions within the coding sequence.

For example:

HLA-B*15:02:01

The additional field may indicate a coding-sequence difference that does not alter the amino acid sequence.

Fourth Field

The fourth field identifies differences in non-coding regions, such as introns or untranslated regions:

HLA-B*15:02:01:01

These differences may be important for complete genomic characterization, research, sequence databases, or specialized assay development, but they may not be required for every routine typing report.

The HLA allele naming system uses up to four numerical fields, with the level of detail depending on the sequence differences between the allele and its closest relatives.

HLA-B15:02 and HLA-B1502: Are They Different?

No. HLA-B*15:02 is the modern colon-based format, while HLA-B*1502 is an older format without colons.

The two names describe the same two-field allele designation:

• Modern format: HLA-B*15:02

• Legacy format: HLA-B*1502

Older publications, product documents, databases, and laboratory software may still display the non-colon format. When comparing records, the formatting difference should not automatically be interpreted as a genotype discrepancy.

However, laboratories should use one consistent reporting format in their own systems and confirm that software, databases, certificates, and result reports apply the same nomenclature convention.

What Does Typing Resolution Mean?

HLA typing resolution describes the level of detail that an assay can distinguish and report.

Resolution is not simply a measure of whether one test is “better” than another. It describes the amount of sequence information available from the result. The appropriate resolution depends on the purpose of the assay.

For example, a screening assay may only need to determine whether an allele group is present. A transplantation workflow may require a more detailed allele-level result. A sequencing research project may need full-gene or genomic-level information.

Common HLA Typing Resolution Levels

Terminology such as “low resolution,” “intermediate resolution,” and “high resolution” may vary between laboratories, organizations, and applications. For this reason, a report should specify the actual allele format rather than relying only on a general resolution label.

Why HLA-B*15:02 Is a Useful Example

HLA-B*15:02 is frequently discussed because it is relevant to targeted pharmacogenomic testing involving carbamazepine-associated severe cutaneous adverse reactions. The CPIC guideline for HLA-B and carbamazepine provides clinical interpretation guidance for this type of genotype result.

From a laboratory perspective, the important point is that an assay must reliably distinguish the required allele from other members of the HLA-B*15 family. A result reported only as HLA-B*15 may not provide the same information as HLA-B*15:02.

This example demonstrates why nomenclature and resolution matter. The test design, reference material, analysis software, and final report must all support the allele distinction required by the intended application.

How Typing Resolution Affects Assay Design

Typing resolution influences nearly every stage of an HLA assay.

Primer and Probe Design

A targeted assay must be designed around the sequence differences that distinguish the intended allele from related alleles. If the assay is expected to report HLA-B*15:02, the primers or probes must detect the relevant sequence features with sufficient specificity.

An assay designed only to identify the broader HLA-B*15 family may not be appropriate when a two-field result is required.

Sequencing Coverage

For sequence-based typing, the regions included in the assay determine which level of resolution can be supported. If the assay only covers a limited coding region, it may not distinguish alleles that differ outside that region.

A high read count cannot compensate for missing target regions. Resolution depends on target design, sequence quality, read length, phasing, and the reference database used for allele assignment.

Software and Allele Databases

HLA allele assignment software compares observed sequence data with known allele sequences. The database version and nomenclature format can affect the final result.

Laboratories should document:

• The HLA database version used

• The allele naming format

• The reporting resolution

• Rules for ambiguous allele assignment

• How newly named alleles are handled

• Whether legacy and colon-based names are normalized

Result Reporting

The report should make clear whether the result is reported at the antigen, allele-group, two-field, three-field, or four-field level.

For example, these results do not contain the same amount of information:

• HLA-B15

• HLA-B*15

• HLA-B*15:02

• HLA-B*15:02:01

• HLA-B*15:02:01:01

A laboratory should not report a more detailed designation than its assay and evidence support.

Selecting a Reference Standard for the Required Resolution

Reference standards should match the assay’s target locus, intended reporting level, and testing technology.

For a focused HLA-B assay, a single-locus HLA genotyping standard may provide a practical control material for evaluating a defined allele such as HLA-B*15:02. CB-Gene’s single HLA locus standards are mainly designed around focused HLA typing applications and include HLA-B reference materials.

When an assay reports multiple HLA loci for matching or transplantation-related applications, a multi-locus HLA matching standard may be more appropriate. The standard should contain assigned results at the loci and resolution relevant to the laboratory’s intended workflow.

A high-resolution reference material can contain more sequence information than a low-resolution assay reports. However, the laboratory must define how the higher-resolution assigned genotype will be evaluated against the assay’s reporting level. A detailed reference result does not automatically prove performance in sequence regions that the assay does not test.

HLA reference standards for assay validation and quality control can provide additional background on how characterized materials are used to assess expected results, repeatability, and workflow consistency.

Common Interpretation Mistakes

Confusing an Allele Group With a Specific Allele

HLA-B*15 does not identify the same level of detail as HLA-B*15:02. The first is an allele group, while the second is a two-field allele designation.

Treating Serology and DNA Nomenclature as Interchangeable

A serological antigen such as B15 and a sequence-defined allele group such as B*15 may be related, but they are not identical reporting systems.

Assuming More Fields Always Mean Better Clinical Relevance

Third- and fourth-field differences may be important for research or complete sequence characterization, but they may not affect the reporting requirement of every assay.

Reporting Unsupported Precision

If an assay cannot distinguish HLA-B*15:02:01 from another allele with the same tested sequence, it should not report the third-field designation as though it were directly demonstrated.

Ignoring Legacy Formats

Older records may use HLA-B*1502 rather than HLA-B*15:02. Format differences should be normalized before comparing results across databases or publications.

Conclusion

HLA allele nomenclature provides a structured way to describe sequence-defined variants across the highly polymorphic HLA system. In HLA-B*15:02, HLA-B identifies the locus, the asterisk separates the gene from the allele designation, 15 identifies the allele family, and 02 identifies a specific protein-level subtype.

Additional fields provide information about synonymous coding changes and non-coding sequence differences. The difference between HLA-B*15:02 and HLA-B*15:02:01:01 is therefore a difference in reporting detail, not necessarily a difference in the primary protein sequence.

Typing resolution should be selected according to the assay’s intended use. Laboratories should define the required resolution before designing primers, choosing sequencing targets, selecting software, or ordering reference materials. A suitable HLA standard should match the locus, allele designation, assay scope, and reporting requirements.

HLA genotyping assay validation checklist can be used as the next step when translating the selected nomenclature and resolution into a documented validation plan.

FAQs

What Does HLA-B*15:02 Mean?

HLA-B*15:02 identifies a specific allele at the HLA-B locus. B is the gene, 15 is the allele family, and 02 identifies a protein-level subtype within that family.

Is HLA-B15:02 the Same as HLA-B1502?

Yes. HLA-B*15:02 is the modern colon-based format, while HLA-B*1502 is a legacy format for the same two-field allele designation.

What Is the Difference Between HLA-B15 and HLA-B15:02?

HLA-B*15 identifies an allele group, whereas HLA-B*15:02 identifies a specific two-field allele. The latter provides more sequence-level information.

Does a Four-Field Result Always Mean a Better HLA Test?

Not necessarily. A four-field result provides more sequence detail, but the appropriate resolution depends on the assay’s purpose, reporting requirements, and validated analytical scope.

Which HLA Reference Standard Should Be Used for HLA-B*15:02?

A single-locus HLA reference standard containing the assigned HLA-B*15:02 genotype may be suitable for a focused HLA-B assay. The final selection should also consider the assay method, material format, verification data, and required reporting resolution.